KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Restructuring Costs (2016 - 2026)

Johnson & Johnson's Restructuring Costs history spans 14 years, with the latest figure at $32.0 million for Q1 2026.

  • On a quarterly basis, Restructuring Costs rose 88.24% to $32.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $243.0 million, a 179.31% increase, with the full-year FY2025 number at $228.0 million, down 2.56% from a year prior.
  • Restructuring Costs hit $32.0 million in Q1 2026 for Johnson & Johnson, down from $84.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for JNJ hit a ceiling of $164.0 million in Q1 2024 and a floor of -$13.0 million in Q2 2024.
  • Historically, Restructuring Costs has averaged $77.0 million across 5 years, with a median of $65.0 million in 2022.
  • Biggest five-year swings in Restructuring Costs: plummeted 108.97% in 2024 and later soared 592.31% in 2025.
  • Tracing JNJ's Restructuring Costs over 5 years: stood at $65.0 million in 2022, then decreased by 13.85% to $56.0 million in 2023, then fell by 25.0% to $42.0 million in 2024, then skyrocketed by 100.0% to $84.0 million in 2025, then plummeted by 61.9% to $32.0 million in 2026.
  • Business Quant data shows Restructuring Costs for JNJ at $32.0 million in Q1 2026, $84.0 million in Q4 2025, and $63.0 million in Q3 2025.